ArticleJournal of pharmacy & bioallied sciences2025
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The current study evaluated the osteogenic potential of three commercially available autogenous bone graft materials using primary human osteoblasts. Materials and Methods: Primary human osteoblasts were seeded onto the bone graft materials, and their adhesion, proliferation, and gene expression (Runx2 and ALP) were assessed at 4, 8, 3, and 14 days post-seeding. The materials were grouped (Group I: biphasic calcium phosphate (BCP), Group II: freeze-dried bone allografts (FDBA), Group III: deproteinized bovine bone mineral (DBBM)) and characterized for particle size and mean projection area. A two-way analysis of variance (ANOVA) with Bonferroni's correction was used for statistical analysis. Results: Group I showed the highest osteoblast adhesion and proliferation, with the highest expression of osteogenic markers, followed by Group II and Group III. Group I had the smallest particle size. Conclusion: Deproteinized bovine bone mineral may be the most effective bone graft material for promoting osteogenesis, with implications for optimizing bone graft selection in oral surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.